Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Support Care Cancer. 2020 Aug 15;29(4):1913–1921. doi: 10.1007/s00520-020-05674-9

Table 2:

Sociodemographic and clinical characteristics of the Illinois Rural Cancer Assessment respondents by post-treatment communication and follow-up care utilization (n = 139)

PPCQ1
Overall High Low/Medium p-value
N (%) 139 100% 45 32% 94 68% --
SOCIODEMOGRAPHIC CHARACTERISTICS
Age, Mean (SD)2 58.09 12.10 58.73 12.4 57.79 12.00 0.67
Gender, n (%)3 0.04
 Male 24 17% 12 27% 12 13%
 Female 115 83% 33 73% 82 87%
Race, n (%)3 0.62
 Non-Hispanic White 126 91% 40 89% 86 92%
 Other 13 9% 5 11% 8 8%
Marital Status, n (%)3 0.87
 Married 97 70% 31 69% 66 70%
 Not married 42 30% 14 31% 28 30%
Education, n (%) 3 0.17
 <Bachelor’s Degree 78 56% 29 64% 49 52%
 ≥Bachelor’s Degree 61 44% 16 36% 45 48%
Employment Status, n (%)3 0.44
 Employed 86 62% 26 58% 60 64%
 Not employed 52 37% 19 42% 33 35%
 Missing 1% 0 0 1 1%
Annual household income, n (%)3
 <$50,000 67 48% 26 61% 41 46% 0.12
 ≥$50,001 65 47% 17 40% 48 54%
 Missing 7 5% 2 4% 5 5%
Private insurance, n (%)3 0.35
 Yes 79 57% 23 51% 56 40%
 No 60 43% 22 49% 38 60%
Socioeconomic composite (education, income, and insurance)2,4 0.14
 Tertile 1 (Range: −2.47 to −0.47) 43 31% 19 42% 24 26%
 Tertile 2 (Range: −0.37 to 0.52) 43 31% 11 24% 32 34%
 Tertile 3 (Range: 0.62 to 1.30) 46 33% 13 29% 33 35%
 Missing 7 5% 2 4% 5 5%
County rurality5 0.09
 Populations of ≥20,000 (RUCC <4) 54 39% 22 49% 32 34%
 Populations of <20,000 (RUCC 4+) 85 61% 23 51% 62 66%
CLINICAL COVARIATES
Cancer Sites, n (%)3,6 0.94
 Breast cancer 58 41.7 19 42% 39 42%
 Other 81 58.3 26 58% 55 59%
Currently being Treated, n(%) 0.31
 Yes 42 30% 11 24% 31 33%
 No 97 70% 34 76% 63 67%
Total Comorbidities, M (SD)2,7
5.40 3.26 4.89 3.14 5.65 3.30 0.20
Treatment-related symptoms (Global Distress), M (SD)2,8
0.78 078 0.55 0.67 0.88 0.81 0.02
QUALITY OF LIFE (QOL), M (SD)2,9
 Social Well-being 18.64 5.7 17.91 5.38 20.16 4.39 0.02
 Functional Well-being 19.75 6.45 18.73 6.18 21.87 6.55 0.007
 Physical Well-being 21.55 5.46 21.00 5.39 22.69 5.51 0.09
1

Patient Provider Communication was measured 4-item survey instrument from the Medical Expenditure Panel Survey’s (MEPS). [34] Experience with Cancer Care section

2

Mean values, standard deviations, and p-values were obtained by accessing between group different between high patient-provider communication and low/medium patient provider communication using one-way ANOVA tests within SPSS.

3

Frequencies, percentages, and p-values were obtained by conducting Person chi-squared tests within SPSS.

4

Teritles were created based on the SES composite score with the maximum value of 1.30 indicating most disadvantaged and the minimum value of −2.47 indicating least disadvantage.

5

Rural Urban Continuum Code (RUCC). RUCC 1–3 codes incorporate populations with ≥20,000 residents in metropolitan areas. RUCC 4–9 incorporate urban and completely rural areas with populations of <20,000.

6

Other within this category includes the following cancer sites: testicular, melanoma, skin, lung, bone, kidney, bladder, stomach, prostate, pancreatic, thyroid, colon, liver, rectal, Hodgkins Lymphoma, non-Hodgkins Lympohma, and leukemia.

7

Data were derived from the Comorbidity Questionnaire [35]. Responses for comorbidities are dichotomous with participants selecting either “yes” or “no.” The ranges are respectively 0 to 14.

8

Global Distress was measured by the 24 items of the Memorial Symptom Assessment Scale (MSAS). 0–4 was the possible range for this variable [36].

9

Range values social well-being, functional well-being, and physical well-being are 0–28 with higher scores indicating better quality of life [33].

HHS Vulnerability Disclosure